HDAC9 and acute myeloid leukemia: To this end, we sought to examine whether and how the menin-MLL interaction inhibitor MI-3, which acts to inhibit transcription of MLL target genes, would interact with the HDAC inhibitor chidamide, a class of epigenetic agents that regulate gene expression through chromatin remodeling, in MLL-r AML.